What the FDA Actually Cleared When UpDoc Became the First Patient-Facing LLM Medical Device: A Stanford Insulin-Titration Trial, a Drug-Dose-Calculator Predicate, and the Real Shape of Clinical AI

The FDA just cleared the first patient-facing LLM medical device. The headline says it redefined clinical AI. The actual clearance file tells a more interesting story.

Pull up K253281 and the intended use is: basal insulin management in adults with type 2 diabetes. Not general clinical AI. Not autonomous care. One job, one population, by prescription. Th…